This report presents the findings from a survey of 102 pharmaceutical companies regarding their Information & Communications Technology (ICT) budgets and staff allocation. The survey investigates how pharmaceutical companies currently allocate their ICT budgets across the core areas of ICT spend, namely hardware, software, IT services, communications and consulting.
Understand how ICT budgets are set to change in 2013 in terms of their overall size.
Appreciate how budgets are allocated across the core elements of ICT spend, including hardware, software, services, communications and consulting.
Learn how ICT money is being spent in areas such as the data centre, applications, IT management and the network.
Establish how IT staff are typically allocated within pharmaceuticals industry.
Gain insight into with whom pharmaceutical companies plan to spend their ICT money.
Why was the report written?
In order to provide a depth of insight into ICT vendors and service providers potential customers.
What is the current market landscape and what is changing?
Kables survey shows that overall ICT spending in the pharmaceutical sector is set to increase in 2013 compared to 2012, with the highest proportion of the average ICT budget being allocated to hardware, followed by software and IT services.
What are the key drivers behind recent market changes?
Emerging technology trends such as thin client computing devices, analytical & business intelligence tools, and cloud computing services are heavily influencing ICT investments in the sector. Increasing compliance regulations are also compelling pharmaceutical companies to invest in IT security solutions.
What makes this report unique and essential to read?
Kable Global ICT Intelligence has invested significant resources in order to interview CIOs and IT managers about their IT Budgets. Very few IT analyst houses will have interviewed 100+ ICT decision makers in the pharmaceuticals industry in H2 2012.
Reasons To Buy
In order to store and manage the rising volume of clinical data, pharmaceutical companies have been making significant investments in their data centres in 2013.
Pharmaceutical companies are allocating a major portion of their ICT budgets to core ICT infrastructure in order to improve their business processes to respond well in this highly regulated and challenging market place.
With an increasingly geographically dispersed employee base, pharmaceutical companies are keen to invest in network and communications technologies.
The survey also shows that pharmaceutical companies are spending a noticeable portion of their IT services budgets on security & privacy services, in order to maintain a competitive edge amidst increasing regulatory demands for data protection.
The proportional spend with technology (product) vendors and specialist outsourcers are both likely to drop by in 2013 compared to 2012, as companies look to bring more of their ICT investments in-house.
Table of Contents1 Trends in ICT budgets
1.2 Survey demographics
1.3 ICT budget changes
1.4 ICT budget allocation by core technology area
1.5 ICT budget allocation by function
1.6 ICT spending by entity
1.7 IT staff distribution
2 Detailed ICT budget allocations
2.2 Hardware budget breakdown
2.3 Software budget breakdowns
2.4 Third party IT services expenditure
2.5 Telecommunications budget
3.1 The pharmaceutical industry is devising ICT strategies to better support its business needs
4.2 Further reading
4.3 Contact the authorsList Of TablesTable 1: Pharmaceuticals â enterprise ICT survey geographic breakdown
Table 2: Pharmaceuticals â enterprise ICT survey breakdown by size band (number of employees)
Table 3: Recent and expected ICT budget changes among pharmaceutical companies
Table 4: Pharmaceutical companiesâ (external) ICT budget allocation, 2012 and 2013
Table 5: Pharmaceutical companiesâ ICT budget allocation by function, 2012 and 2013
Table 6: Pharmaceutical companiesâ (external) ICT budget allocation by entity, 2012 and 2013
Table 7: Average allocation of full-time IT staff members in pharmaceutical companies
Table 8: Pharmaceutical companiesâ average hardware budget allocation
Table 9: Average allocation of software budgets in pharmaceutical companies
Table 10: Pharmaceutical companiesâ average software budget allocation by technology
Table 11: Pharmaceutical companiesâ average IT services budget allocation
Table 12: Pharmaceutical companiesâ average IT consulting services budget allocation
Table 13: Pharmaceutical companiesâ average telecommunications budget allocationList Of FiguresFigure 1: Pharmaceuticals â enterprise ICT survey geographic breakdown
Figure 2: Pharmaceuticals â enterprise ICT survey breakdown by size band (number of employees)
Figure 3: Recent and expected ICT budget changes among pharmaceutical companies
Figure 4: Pharmaceutical companiesâ (external) ICT budget allocation, 2012 and 2013
Figure 5: Pharmaceutical companiesâ ICT budget allocation by function, 2012 and 2013
Figure 6: Pharmaceutical companiesâ ICT budget allocation by entity, 2012 and 2013
Figure 7: Average allocation of full-time IT staff members in pharmaceutical companies
Figure 8: Pharmaceutical companiesâ average hardware budget allocation
Figure 9: Average allocation of software budgets in pharmaceutical companies
Figure 10: Pharmaceutical companiesâ average software budget allocation by technology
Figure 11: Pharmaceutical companiesâ average IT services budget allocation
Figure 12: Pharmaceutical companiesâ average IT consulting services budget allocation
Figure 13: Pharmaceutical companiesâ average telecommunications budget allocation